Amepromat en es it fr

Amepromat Brand names, Amepromat Analogs

Amepromat Brand Names Mixture

  • No information avaliable

Amepromat Chemical_Formula


Amepromat RX_link

No information avaliable

Amepromat fda sheet

Amepromat msds (material safety sheet)

Amepromat Synthesis Reference

No information avaliable

Amepromat Molecular Weight

309.469 g/mol

Amepromat Melting Point

< 25 oC

Amepromat H2O Solubility

Soluble as HCl salt

Amepromat State


Amepromat LogP


Amepromat Dosage Forms

Tablets (oral, 1 mg)

Amepromat Indication

Used for the symptomatic treatment of parkinsonism.

Amepromat Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Amepromat Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Amepromat side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Amepromat Patient Information

Amepromat Organisms Affected

Humans and other mammals